These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 36200)

  • 1. beta-Blocker and renal function.
    Jackson DA
    Br Med J; 1979 Apr; 1(6171):1149. PubMed ID: 36200
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Kö 1366 on the distribution of intrarenal blood flow in normal canine kidneys.
    Nakamura M; Nose Y; Tomoike H; Shirai T; Kuroiwa A
    Arzneimittelforschung; 1974 Sep; 24(9):1325-8. PubMed ID: 4154766
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
    Okajima K; Harada N; Uchiba M; Isobe H
    J Pharmacol Exp Ther; 2004 May; 309(2):684-91. PubMed ID: 14764656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of celiprolol on peripheral circulation in healthy volunteers.
    Ehringer H; Konecny U; Rasser W
    Br J Clin Pract Suppl; 1985 Jun; 40():91-9. PubMed ID: 2864073
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tertatolol--characteristics of the drug].
    Tomaszewski R; Kliz J
    Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Beta receptors and renin release.
    Amery A; Billiet L; Fagard R
    N Engl J Med; 1974 Jan; 290(5):284. PubMed ID: 4148766
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of some beta-adrenergic blocking drugs on the renal bloow flow in dogs.
    Abdel-Razzak M
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):227-34. PubMed ID: 23082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in beta blockade. Therapeutic implications in hypertension. Proceedings of the First International Symposium on Tertatolol, 15th June, 1985, Milano, Italy.
    Am J Nephrol; 1986; 6 Suppl 2():1-116. PubMed ID: 2879463
    [No Abstract]   [Full Text] [Related]  

  • 10. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of clinical usefulness of beta-blocker in aged and younger essential hypertension. Double blind trial using bunitrolol].
    Kuramoto K; Ikeda M; Arakawa K; Inagaki Y; Kaneko Y; Masuyama Y; Yamazaki N; Tsuchiya M
    Nihon Ronen Igakkai Zasshi; 1984 Jan; 21(1):20-6. PubMed ID: 6145808
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in renal functions during beta-blocker carazolol administration in acute heat-stressed pigs.
    Chaiyabutr N; Buranakari C; Tesaprateep T; Loypetjra P
    Br Vet J; 1987; 143(5):448-53. PubMed ID: 2890402
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metoprolol (Lopressor).
    Med Lett Drugs Ther; 1978 Nov; 20(22):97-8. PubMed ID: 30035
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nadolol, a long-acting beta-blocker, in the treatment of essential arterial hypertension].
    Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
    Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765448
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal blood flow during nadolol administration.
    N Engl J Med; 1983 Jan; 308(1):49-50. PubMed ID: 6128676
    [No Abstract]   [Full Text] [Related]  

  • 19. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jul; 20(1):1-23. PubMed ID: 6105067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological studies of the effect of beta-blocker in drug induced ocular hypertension. 2. Ocular hypertension following the topical application of prostaglandin E2].
    Nishimura T; Yamashita H; Makiura M; Hiramatsu K; Uyama M
    Nippon Ganka Gakkai Zasshi; 1983; 87(10):818-26. PubMed ID: 6143476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.